Centessa Pharmaceuticals, a wholly owned subsidiary of Eli Lilly and Company, is a clinical-stage company developing orexin receptor 2 (OX2R) agonists as a new class of medicines for the treatment of narcolepsy and potentially other sleep-wake disorders. Centessa's lead investigational candidate – cleminorexton (formerly ORX750) – is being developed for narcolepsy type 1, narcolepsy type 2, and idiopathic hypersomnia. Centessa's OX2R agonist portfolio includes additional clinical and preclinical-stage assets with potential utility across a broader range of neurological, neurodegenerative, and neuropsychiatric conditions. Headquartered in Boston, Massachusetts, Centessa was recognized as a Great Place to Work® in 2026. The Senior Director of Patient Advocacy will lead the development and execution of the company's patient advocacy and engagement strategy, ensuring the patient voice is embedded across clinical development, corporate strategy, disease awareness, and future commercialization efforts. Partnering closely with executive leadership, cross-functional teams, and colleagues within our parent organization, this individual will help develop and implement a strategic framework for incorporating patient perspectives into key business, development, and commercialization decisions. The role will build advocacy partnerships, drive patient-centered initiatives, influence decision-making, and advance measurable improvements in patient outcomes, disease awareness, clinical trial engagement, and access.
Stand Out From the Crowd
Upload your resume and get instant feedback on how well it matches this job.
Job Type
Full-time
Career Level
Senior